The Synthesis and Characterization of 2-Amino-3-methylpyridinium Dihydrogenmonophosphate: (C6H9N2)H2PO4

A new crystal of 2-amino-3-methylpyridinium dihydrogenmonophosphate has been prepared and characterized by X-ray crystallography, thermal analysis, and impedance and NMR spectroscopies. This compound crystallizes in the triclinic space group P with a = 7.343(2) Å, b = 7.987(2) Å, c = 8.116(4) Å, α = 77,62(3)°, β = 77,74(3)°, γ = 87,03(2)°, V = 454.3 (3)ų, and Z = 2. The crystal structure was solved and refined to R = 0.030 with 1602 independent reflections. The atomic arrangement can be described as (H₂PO₄ ^?)_n polymeric chains anchoring the 2-amino-3-methylpyridinium cations through short hydrogen bonds. All ring atoms of the organic entity are coplanar. The exocyclic N atom is an electron receiving center, which is consistent with features of imino resonance evidenced by bond lengths and angles. Solid state ³¹P, ¹³C, and ¹⁵N CP-MAS-NMR spectroscopies are in agreement with the X-ray structure. Ab initio calculations allow the attribution of carbons and nitrogen to the independent crystallographic sites.     

2-氨基-6-甲氧基-3-硝基吡啶的合成

以2-氯-5-硝基吡啶为原料,经甲氧基化反应得2-甲氧基-5-硝基吡啶(2),2再与液氨/高锰酸钾进行氨化反应制得2-氨基-6-甲氧基-3-硝基吡啶,总收率77%。     

Synthesis and Properties of 2-Amino-6-nitroindoles

A new method is proposed for the synthesis of 2-amino-6-nitroindoles, based on the reaction of 2-haloanilines and substituted acetonitriles. The reaction of 2-amino-6-nitroindoles with -dicarbonyl compounds was studied.     

Synthesis of Substituted 2-Amino-6H-1,3-oxazin-6-ones

Derivatives of the unknown 2-amino-6H-1,3-oxazin-6-one 2 have been synthesized for the first time in two steps and in excellent yields, starting from N-cyanocarbonimidates 3a – c and cyanoacetates. The structures of 2a – c are assigned by NMR-spectroscopic methods and corroborated by an X-ray structure analysis of 2c .     

Mechanism of the 2-ethyl-3-hydroxy-6-methylpyridinium 2-nitroxysuccinate reduction in nitrite-generating systems

1. Download : Download high-res image (99KB)
2. Download : Download full-size image

     

Synthesis of 5''''-3H-2-Amino-6-cyclopropylaminopurine Nucleosides

We have described a novel use of the D4G prodrug (Cyclo-D4G) approach to stabilize the nucleoside and maintain the anti-HIV activity. β-D-Dioxolanyl-2-amino-6-cyclopropylaminopurine (10, DACP) was synthesized as a prodrug of β-D-dioxolanyl guanine (DXG) and showed potent anti-HIV activity in vitro (EC50=0.18 μmol·L-1 The pharmacokinetics of Cyclo-D4G and DACP following intravenous and oral administration of DACP to rhesusmonkeys and rats did not give D4G and DXG as detectable metabolic products by HPLC. Therefore the radio labeled Cyclo-D4G and DACP are necessary for the pharmacokinetics studies in detail.     

2-Amino-6-phenyl-7,8-dihydroindazolo[4,5-d]thiazoles

Treatment of 4-oxo-l -phenyl-4,5,6,7-tetrahydroindazole and its 3-methyl, 6-phenyl, and 3-methyl-6 phenyl substituted derivatives with pyridinium bromide-perbromide and subsequent reaction of the 5-brorno derivatives obtained with thiourea gave 2-amino-6 phenyl-7, 8-dihydroindazolo[4,5-d]thiazole and its corresponding substituted derivatives. The condensation of these products with 2 formyldimedone led to their 4, 4-dimethyl-2, 6-dioxocyclohexylidene derivatives.Translated from Khimiya Geterotsiklicheskikh Soedinenii, No. 4, pp. 497–500. April, 1966.     

Improved Synthesis of Monoprotected 5- and 6-Amino-2-azanorbornanes

An improved synthesis of Boc-monoprotected 5- and 6-amino-2-azanorbornanes is reported. The synthetic scheme consists of five steps and allows multigram quantities of the title compounds to be obtained. The regio- and stereochemistries of the products are established by two-dimensional NMR experiments.

Reactions of 2-Amino-4-methyl-6-(2-pyridyl)- and 2-Amino-4-methyl-6-phenyl-7,8-dihydroindazolo[4,5-d]thiazoles with Aldehydes

The reaction of 2-amino-4-methyl-6-(2-pyridyl)-7,8-dihydroindazolo[4,5-d]thiazole, obtained by treating 3-methyl-4-oxo-1-(2-pyridyl)-4,5,6,7-tetrahydroindazole with pyridinium bromide perbromide and then with thiourea, and 2-amino-4-methyl-6-phenyl-7,8-dihydroindazolo[4,5-d]thiazole with 4-bromo-, 4-fluoro-, 4-dimethylamino-, 4-methoxy-, 3,4-dimethoxy-, and 3,4-methylenedioxybenzaldehydes, furfural, pyridinecarbaldehyde, and thiophenecarbaldehyde gave the corresponding Schiff bases. The products of the condensation of these aminothiazoles with cinnamaldehyde, 1-(2-pyridyl)- and 4-chloro-1-(2,4-difluorophenyl)-5-formyl-3-methyl-6,7-dihydroindazoles, 2-formyl-dimedone, and 2-formyl-1,3-indanedione were also obtained.     

6-取代氨基-2-烷硫基腺苷化合物的合成及抗血小板凝聚活性

以鸟苷(1)为原料, 经过糖环保护得到2',3',5'-三-O-乙酰基鸟嘌呤核苷(2), 化合物2与三氯氧磷反应得到2-氨基-6-氯-9-(2',3',5'-三-O-乙酰基-β-D-呋喃核糖基)嘌呤(3), 化合物3经重氮化后再与二烷基二硫醚反应得到2-烷硫基-6-氯-9-(2',3',5'-三-O-乙酰基-β-D-呋喃核糖基)嘌呤(4a~4d), 化合物4a~4d与胺进行亲核取代反应后, 脱去糖环保护得到12个新型的6-取代氨基-2-烷硫基腺苷化合物(5a~5l). 采用¹H NMR, ¹³C NMR, IR和高分辨质谱(HRMS)对目标化合物的结构进行了确证, 并对所有化合物进行了体外抗血小板聚集活性测试. 结果表明, 当测试浓度为10 μmol/L时, 化合物5a~5l仍具有一定的抗凝活性, 其中, 6-(3-苯基丙基)氨基-2-丙硫基腺苷(5d)活性最为显著, 抑制率可达90.2%.